$638 Million is the total value of SECTOR GAMMA AS's 31 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 34.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABT | Sell | ABBOTT LABS | $72,062,000 | +11.0% | 982,312 | -7.7% | 11.30% | +4.7% |
| BAX | Sell | BAXTER INTL INC | $54,443,000 | +2.3% | 706,228 | -2.1% | 8.54% | -3.5% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $53,260,000 | +11.5% | 1,383,374 | -5.3% | 8.35% | +5.1% |
| MRK | Sell | MERCK & CO INC | $51,860,000 | -6.5% | 731,046 | -20.0% | 8.13% | -11.8% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $44,752,000 | -10.4% | 720,880 | -20.1% | 7.02% | -15.4% |
| SHPG | Buy | SHIRE PLCsponsored adr | $37,207,000 | +28.3% | 205,256 | +19.5% | 5.83% | +21.0% |
| PKI | Buy | PERKINELMER INC | $35,901,000 | +35.1% | 369,081 | +1.7% | 5.63% | +27.4% |
| BIO | Buy | BIO RAD LABS INCcl a | $30,265,000 | +21.3% | 96,697 | +11.9% | 4.74% | +14.4% |
| NUVA | Buy | NUVASIVE INC | $28,053,000 | +43.2% | 395,223 | +5.2% | 4.40% | +35.1% |
| GILD | Buy | GILEAD SCIENCES INC | $24,953,000 | +20.8% | 323,187 | +10.8% | 3.91% | +14.0% |
| ANTM | Sell | ANTHEM INC | $22,887,000 | +9.4% | 83,513 | -5.0% | 3.59% | +3.2% |
| IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $22,312,000 | +6.0% | 338,733 | +3.7% | 3.50% | +0.0% |
| PRGO | Buy | PERRIGO CO PLC | $22,176,000 | +52.5% | 313,220 | +57.0% | 3.48% | +43.9% |
| A | New | AGILENT TECHNOLOGIES INC | $15,046,000 | – | 213,300 | +100.0% | 2.36% | – |
| INCY | New | INCYTE CORP | $14,767,000 | – | 213,764 | +100.0% | 2.32% | – |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $13,425,000 | +22.1% | 105,012 | +6.5% | 2.10% | +15.2% |
| BIIB | New | BIOGEN INC | $12,719,000 | – | 36,000 | +100.0% | 1.99% | – |
| PDCO | Buy | PATTERSON COMPANIES INC | $11,680,000 | +65.0% | 477,707 | +53.0% | 1.83% | +55.7% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $10,442,000 | -17.4% | 202,434 | -33.2% | 1.64% | -22.0% |
| LXRX | LEXICON PHARMACEUTICALS INC | $9,204,000 | -11.1% | 862,602 | 0.0% | 1.44% | -16.1% | |
| CAH | Buy | CARDINAL HEALTH INC | $7,362,000 | +19.4% | 136,335 | +8.0% | 1.15% | +12.6% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $7,238,000 | -74.3% | 182,905 | -77.2% | 1.14% | -75.7% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $7,182,000 | -5.3% | 269,701 | +34.3% | 1.13% | -10.6% |
| RDY | New | DR REDDYS LABS LTDadr | $5,924,000 | – | 171,219 | +100.0% | 0.93% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $5,450,000 | -31.1% | 185,577 | +6.7% | 0.85% | -35.0% |
| ARRY | New | ARRAY BIOPHARMA INC | $5,078,000 | – | 334,100 | +100.0% | 0.80% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $3,977,000 | +24.2% | 45,437 | +39.8% | 0.62% | +17.3% |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $2,627,000 | +26.7% | 154,960 | +6.1% | 0.41% | +19.4% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $2,242,000 | -57.1% | 29,368 | -56.8% | 0.35% | -59.5% |
| ONCE | Buy | SPARK THERAPEUTICS INC | $1,845,000 | -29.4% | 33,814 | +7.0% | 0.29% | -33.6% |
| LLY | Sell | LILLY ELI & CO | $1,465,000 | -90.5% | 13,650 | -92.5% | 0.23% | -91.1% |
| RGNX | Exit | REGENXBIO INC | $0 | – | -10,000 | -100.0% | -0.12% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -17,000 | -100.0% | -0.44% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -90,503 | -100.0% | -0.50% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -423,850 | -100.0% | -1.35% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -51,654 | -100.0% | -1.54% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -28,500 | -100.0% | -1.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.